Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT04554966
Status:
COMPLETED
Last Update Posted:
2024-03-04
First Post:
2020-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-14
First Submit QC Date:
None
Study First Post Date:
2020-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL